These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31127788)

  • 1. δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2019; 70(1):199-210. PubMed ID: 31127788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states.
    Royall DR; Palmer RF
    Alzheimers Dement (Amst); 2017; 6():214-221. PubMed ID: 28378011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. δ scores predict multiple neuropsychiatric symptoms.
    Royall DR; Palmer RF
    Int J Geriatr Psychiatry; 2020 Nov; 35(11):1341-1348. PubMed ID: 32584472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.
    Royall DR; Palmer RF; Markides KS
    J Gerontol B Psychol Sci Soc Sci; 2017 Oct; 72(6):947-955. PubMed ID: 26968639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. δ Scores are Exportable Across Cultural and Linguistic Boundaries.
    Royall DR; Palmer RF; Matsuoka T; Kato Y; Taniguchi S; Ogawa M; Fujimoto H; Okamura A; Shibata K; Nakamura K; Nakaaki S; Koumi H; Mimura M; Fukui K; Narumoto J
    J Alzheimers Dis; 2016; 49(2):561-70. PubMed ID: 26444764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INFLAMMATION's cognitive impact revealed by a novel "Line of Identity" approach.
    Royall DR; Palmer RF
    PLoS One; 2024; 19(3):e0295386. PubMed ID: 38517924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Dementia Severity is Almost Entirely Explained by the Latent Variable δ's Intercept and Slope.
    Palmer RF; Royall DR
    J Alzheimers Dis; 2016; 49(2):521-9. PubMed ID: 26444763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Potential Telephone Assessment of Dementia Prevalence and Severity.
    Royall DR; Palmer RF
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):202-207. PubMed ID: 29458281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria.
    Marcos G; Santabárbara J; Lopez-Anton R; De-la-Cámara C; Gracia-García P; Lobo E; Pírez G; Menchón JM; Palomo T; Stephan BC; Brayne C; Lobo A;
    Acta Psychiatr Scand; 2016 May; 133(5):378-85. PubMed ID: 26685927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).
    Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Adipokines Predict Dementia Severity as Measured by δ: Replication Across Biofluids and Cohorts.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2023; 92(2):639-652. PubMed ID: 36776066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
    Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.